|

Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • John Lister1

Indications

  • Transformed Lymphoma1
  • Lymphoplasmacytic Lymphoma1
  • B Acute Lymphoblastic Leukemia1
  • Chronic Lymphocytic Leukemia1
  • B Cell Lymphoma1

Pittsburgh, Pennsylvania1 trial

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

AHN Cancer Institute - West Penn Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.